Cardano Risk Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$299M Sell
249,204
-1,637
-0.7% -$1.67M 2.3% 10
2026
Q1
$231M Buy
250,841
+13,336
+6% +$13.5M 2.26% 11
2025
Q4
$255M Sell
237,505
-5,811
-2% -$5.56M 2.57% 11
2025
Q3
$186M Buy
243,316
+6,799
+3% +$5.06M 1.97% 13
2025
Q2
$184M Buy
236,517
+11,763
+5% +$9.14M 2.36% 14
2025
Q1
$186M Buy
224,754
+6,239
+3% +$5.19M 2.95% 12
2024
Q4
$169M Buy
218,515
+2,143
+1% +$1.77M 2.59% 13
2024
Q3
$192M Buy
216,372
+2,682
+1% +$2.41M 3.39% 9
2024
Q2
$193M Buy
213,690
+36,710
+21% +$29.4M 3.8% 7
2024
Q1
$138M Buy
176,980
+199
+0.1% +$142K 4.27% 7
2023
Q4
$96.9M Buy
+176,781
New +$103M 4.02% 10

Other funds holding LLY

Cardano Risk Management's LLY Position: Q2 2026 in Review

Cardano Risk Management reduced its Eli Lilly (LLY) stake by 0.65% in Q2 2026, selling an estimated $1.67M and leaving 249,204 shares worth $299M. The position accounts for 2.3% of the portfolio, ranked #10.

Cardano Risk Management first reported a position in LLY in Q4 2023 and has held it in 11 quarters since. 1,252 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Cardano Risk Management held 249,204 shares of Eli Lilly worth $299M as of Q2 2026.
  • Cardano Risk Management sold 1,637 Eli Lilly shares in Q2 2026, an estimated $1.67M.
  • Eli Lilly made up 2.3% of Cardano Risk Management's portfolio in Q2 2026, its #10 holding.
  • Cardano Risk Management first reported a position in Eli Lilly in Q4 2023 and has held it in 11 quarters since.
  • 1,252 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Cardano Risk Management's 13F filing for Q2 2026, filed 9 Jul 2026.